(1 - 15 from 15
)
StreetInsider.com
www.streetinsider.com
Xencor, Inc. (NASDAQ: XNCR), today announced that Kevin Gorman, Ph.D., chief executive officer of Neurocrine Biosciences, has been ...
Neurocrine Biosciences (NBIX) Tops Q2 EPS by 69c ...www.streetinsider.com › Corporate+News
www.streetinsider.com
... disease, and advancing our programs in clinical development," said Kevin Gorman, Ph.D., Chief Executive Officer of Neurocrine Biosciences.
sorted by relevance / date